Disseminated Mycobacterium colombiense Disease in a Person Living with HIV: Diagnostic and Therapeutic Considerations.
- 1Department of Infectious Diseases,The First Affiliated Hospital, Zhejiang University School of Medicine (FAHZU), Hangzhou, Zhejiang, People's Republic of China.
Abstract
Background
Disseminated non-tuberculous mycobacterial (NTM) disease is an uncommon but serious complication in people living with HIV. Rare species such as Mycobacterium colombiense are infrequently reported, and guidance on diagnosis and treatment remains limited. This case illustrates challenges in identifying and managing disseminated M. colombiense infection.Description
A middle-aged man living with HIV presented with disseminated Talaromyces marneffei infection complicated by hemophagocytic lymphohistiocytosis. He received antifungal therapy, immunomodulatory treatment, and antiretroviral therapy. During immune recovery, he developed progressive hepatic lesions and systemic inflammation, followed by osteoarticular involvement. Conventional microbiological tests were repeatedly negative, while metagenomic next-generation sequencing of liver tissue identified Mycobacterium colombiense. The patient was treated with prolonged macrolide-based combination antimycobacterial therapy, alongside corticosteroids for immune reconstitution inflammatory syndrome. Due to focal bone involvement, surgical debridement was performed. Following combined medical and surgical management, clinical symptoms resolved, inflammatory markers improved, and imaging demonstrated regression of lesions.Conclusion
Disseminated M. colombiense infection should be considered in people living with HIV who develop unexplained visceral or skeletal lesions during immune recovery. Early use of molecular diagnostic tools is critical when routine investigations are inconclusive. Prolonged individualized multidrug therapy, combined with selective surgical intervention for focal disease, may improve clinical outcomes in rare NTM infections.
Related
- Disseminated Mycobacterium genavense presenting as recurrent steroid-responsive mesenteric lymphadenitis
- Disseminated Mycobacterium kansasii and Salmonella Typhimurium co-infection following iatrogenic immunosuppression: a case report
- Disseminated Mucor indicus Infection in a Heart Transplant Recipient: Complementary Conventional and Sequencing-Based Diagnostic Approaches
- Multifocal squamous cell carcinoma symmetrically distributed on the feet: Diagnostic considerations
- Posterior Circulation Stroke in Patients With Dizziness: Diagnostic Challenges and Practical Considerations for Emergency Care
BibTeX
@article{xu2026disseminated,
title = {{Disseminated Mycobacterium colombiense Disease in a Person Living with HIV: Diagnostic and Therapeutic Considerations.}},
author = {Tian Zhen Xu and Cai Qin Hu and Biao Zhu and Yi Rui Xie},
journal = {Infection and drug resistance},
year = {2026},
month = oct,
doi = {10.2147/idr.s628257},
url = {https://europepmc.org/article/MED/42910239},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Disseminated Mycobacterium colombiense Disease in a Person Living with HIV: Diagnostic and Therapeutic Considerations.
AU - Tian Zhen Xu
AU - Cai Qin Hu
AU - Biao Zhu
AU - Yi Rui Xie
PY - 2026
DA - 2026/10/17
JO - Infection and drug resistance
DO - 10.2147/idr.s628257
UR - https://europepmc.org/article/MED/42910239
AB - Background Disseminated non-tuberculous mycobacterial (NTM) disease is an uncommon but serious complication in people living with HIV. Rare species such as Mycobacterium colombiense are infrequently reported, and guidance on diagnosis and treatment remains limited. This case illustrates challenges in identifying and managing disseminated M. colombiense infection.Description A middle-aged man living with HIV presented with disseminated Talaromyces marneffei infection complicated by hemophagocytic lymphohistiocytosis. He received antifungal therapy, immunomodulatory treatment, and antiretroviral therapy. During immune recovery, he developed progressive hepatic lesions and systemic inflammation, followed by osteoarticular involvement. Conventional microbiological tests were repeatedly negative, while metagenomic next-generation sequencing of liver tissue identified Mycobacterium colombiense. The patient was treated with prolonged macrolide-based combination antimycobacterial therapy, alongside corticosteroids for immune reconstitution inflammatory syndrome. Due to focal bone involvement, surgical debridement was performed. Following combined medical and surgical management, clinical symptoms resolved, inflammatory markers improved, and imaging demonstrated regression of lesions.Conclusion Disseminated M. colombiense infection should be considered in people living with HIV who develop unexplained visceral or skeletal lesions during immune recovery. Early use of molecular diagnostic tools is critical when routine investigations are inconclusive. Prolonged individualized multidrug therapy, combined with selective surgical intervention for focal disease, may improve clinical outcomes in rare NTM infections.
SN - 1178-6973
ER -